Next Article in Journal
Evolution of National Influenza Vaccine Platform: From Comprehensive Preclinical Safety Validation of Trivalent Influenza Vaccine to Streamlined Immunogenicity of Quadrivalent Formulation
Previous Article in Journal
A Virus-Agnostic Cellular Immunomodulatory Platform for Chronic Respiratory Disease: Restoring Immune Competence and Mitigating Exacerbations in the Elderly
Previous Article in Special Issue
Exploring the Vaccine Adjuvant Effect and Mechanism of Epimedium Using Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations
 
 
Review

Article Versions Notes

Vaccines 2026, 14(6), 476; https://doi.org/10.3390/vaccines14060476
Action Date Notes Link
article html file updated 28 May 2026 19:30 CEST Update https://www.mdpi.com/2076-393X/14/6/476/html
article html file updated 28 May 2026 08:49 CEST Original file -
article pdf uploaded. 28 May 2026 08:47 CEST Version of Record https://www.mdpi.com/2076-393X/14/6/476/pdf
article xml uploaded. 28 May 2026 08:47 CEST Update https://www.mdpi.com/2076-393X/14/6/476/xml
article xml file uploaded 28 May 2026 08:47 CEST Original file -
Back to TopTop